{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:31:39Z","timestamp":1790281899200,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020593","name":"Fundamental Research Funds for the Central Universities of Beijing University of Chemical Technology","doi-asserted-by":"publisher","award":["3332023091"],"award-info":[{"award-number":["3332023091"]}],"id":[{"id":"10.13039\/100020593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","award":["BJ-2023-275"],"award-info":[{"award-number":["BJ-2023-275"]}],"id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clgc.2025.102490","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:14:58Z","timestamp":1766164498000},"page":"102490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of the Oncologic Outcomes of Cryoablation, Laser Ablation, and Hyperthermia for Localized Prostate Cancer: A Population-Based Cohort Study Using the SEER Database"],"prefix":"10.1016","volume":"24","author":[{"given":"Run-Qi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xin","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0003","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0004","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.eururo.2019.10.030","article-title":"Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received","volume":"77","author":"Neal","year":"2020","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102490_bib0005","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","article-title":"The role of focal therapy in the management of localised prostate cancer: a systematic review","volume":"66","author":"Valerio","year":"2014","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0006","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41391-021-00334-3","article-title":"Prostate cancer: a comparison of focal therapy and radical prostatectomy","volume":"25","author":"Marks","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.clgc.2025.102490_bib0007","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.prnil.2022.12.003","article-title":"Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy","volume":"11","author":"Choi","year":"2023","journal-title":"Prostate Int"},{"issue":"7","key":"10.1016\/j.clgc.2025.102490_bib0008","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.21037\/tau-20-1212","article-title":"Focal therapy for primary and salvage prostate cancer treatment: a narrative review","volume":"10","author":"Tracey","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0009","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.euo.2020.12.008","article-title":"A systematic review of focal ablative therapy for clinically localised prostate cancer in comparison with standard management options: limitations of the available evidence and recommendations for clinical practice and further research","volume":"4","author":"Bates","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0010","first-page":"143","article-title":"Review. Current role and future perspectives of hyperthermia for prostate cancer treatment","volume":"23","author":"Baronzio","year":"2009","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.clgc.2025.102490_bib0011","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ultrasmedbio.2018.12.007","article-title":"Ultrasound hyperthermia technology for radiosensitization","volume":"45","author":"Zhu","year":"2019","journal-title":"Ultrasound Med Biol"},{"issue":"17","key":"10.1016\/j.clgc.2025.102490_bib0012","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0013","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10147-020-01847-y","article-title":"Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis","volume":"26","author":"Guo","year":"2021","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102490_bib0014","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1097\/JS9.0000000000001268","article-title":"The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional, and case-control studies in surgery","volume":"110","author":"Rashid","year":"2024","journal-title":"Int J Surg"},{"issue":"11","key":"10.1016\/j.clgc.2025.102490_bib0015","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.6004\/jnccn.2022.0058","article-title":"NCCN Guidelines\u00ae insights: gastrointestinal stromal tumors, version 2.2022","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clgc.2025.102490_bib0016","article-title":"Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.clgc.2025.102490_bib0017","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canep.2017.11.002","article-title":"Older cancer patients in cancer clinical trials are underrepresented. Systematic literature review of almost 5000 meta- and pooled analyses of phase III randomized trials of survival from breast, prostate and lung cancer","volume":"51","author":"Dunn","year":"2017","journal-title":"Cancer Epidemiol"},{"issue":"21","key":"10.1016\/j.clgc.2025.102490_bib0018","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1002\/cncr.34458","article-title":"Oncological and functional outcomes of men undergoing primary whole gland cryoablation of the prostate: a 20-year experience","volume":"128","author":"Tan","year":"2022","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clgc.2025.102490_bib0019","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1089\/end.2020.0740","article-title":"Oncological and functional outcomes of patients undergoing individualized partial gland cryoablation of the prostate: a single-institution experience","volume":"35","author":"Tan","year":"2021","journal-title":"J Endourol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102490_bib0020","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/cas.14889","article-title":"Recent trend of androgen deprivation therapy in newly diagnosed prostate cancer patients: comparing between high- and middle-income Asian countries","volume":"112","author":"Lim","year":"2021","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0021","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eururo.2018.12.030","article-title":"Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry","volume":"76","author":"Shah","year":"2019","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0022","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41391-024-00911-2","article-title":"Established focal therapy-HIFU, IRE, or cryotherapy-where are we now?-a systematic review and meta-analysis","volume":"28","author":"Tay","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.clgc.2025.102490_bib0023","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2016.8.FOCUS16319","article-title":"Introduction: laser ablation techniques","volume":"41","author":"Barnett","year":"2016","journal-title":"Neurosurg Focus"},{"issue":"21","key":"10.1016\/j.clgc.2025.102490_bib0024","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.3390\/cancers14215341","article-title":"Medical device advances in the treatment of glioblastoma","volume":"14","author":"Foo","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2000-12145","article-title":"[Percutaneous interstitial thermotherapy of malignant liver tumors]","volume":"172","author":"Vogl","year":"2000","journal-title":"RoFo"},{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40644-019-0250-4","article-title":"Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT)","volume":"19","author":"Salem","year":"2019","journal-title":"Cancer Imaging"},{"issue":"8","key":"10.1016\/j.clgc.2025.102490_bib0027","article-title":"Multiple glioblastomas ablation by Laser Interstitial Thermal Therapy (LITT): a rare case","volume":"16","author":"Bakrbaldawi","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.clgc.2025.102490_bib0028","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s13311-022-01251-6","article-title":"Updates in IDH-Wildtype Glioblastoma","volume":"19","author":"Melhem","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.clgc.2025.102490_bib0029","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/jpm14121146","article-title":"Percutaneous Magnetic resonance imaging-guided focal laser ablation (MRI-FLA) of prostate tumors: a systematic review and network meta-analysis","volume":"14","author":"Marcelin","year":"2024","journal-title":"J Pers Med"},{"issue":"3","key":"10.1016\/j.clgc.2025.102490_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1442-2042.2006.01272.x","article-title":"Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer","volume":"13","author":"Uchida","year":"2006","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102490_bib0031","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/cancers13051133","article-title":"Salvage-radiation therapy and regional hyperthermia for biochemically recurrent prostate cancer after radical prostatectomy (Results of the Planned Interim Analysis)","volume":"13","author":"Beck","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.clgc.2025.102490_bib0032","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/cells13090754","article-title":"Extracellular vesicles in pathophysiology: a prudent target that requires careful consideration","volume":"13","author":"Shahi","year":"2024","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.clgc.2025.102490_bib0033","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.euo.2024.11.013","article-title":"Targeted microwave ablation for prostate cancer under Magnetic resonance imaging-ultrasound fusion and organ-based tracking: final results from the first phase 2 trial (TMA-HK)","volume":"8","author":"Chiu","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102490_bib0034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nature Rev Neurosci"},{"issue":"4","key":"10.1016\/j.clgc.2025.102490_bib0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/JU.0000000000001126","article-title":"High intensity focused ultrasound hemigland ablation for prostate cancer: initial outcomes of a United States series","volume":"204","author":"Abreu","year":"2020","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0036","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/iju.iju_370_23","article-title":"Irreversible electroporation as a focal therapy for localized prostate cancer: a systematic review","volume":"40","author":"Prabhakar","year":"2024","journal-title":"Indian J Urol"},{"key":"10.1016\/j.clgc.2025.102490_bib0037","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241227055","article-title":"Comparison of efficacy and safety of second-line treatment options for advanced small-cell lung cancer: a retrospective analysis","volume":"23","author":"Zhao","year":"2024","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0038","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102490_bib0039","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.euo.2025.02.003","article-title":"Outcomes of Focal therapy for localized prostate cancer: a systematic review and meta-analysis of prospective studies","volume":"8","author":"\u015alusarczyk","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102490_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOU.0000000000000838","article-title":"Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years","volume":"31","author":"Kayano","year":"2021","journal-title":"Curr Opin Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T03:09:22Z","timestamp":1769224162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1558767325001909"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102490","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Oncologic Outcomes of Cryoablation, Laser Ablation, and Hyperthermia for Localized Prostate Cancer: A Population-Based Cohort Study Using the SEER Database","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102490"}}